News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CytRx Corporation (CYTR) Issues Letter to Stockholders Providing Business Update


5/20/2013 10:25:35 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical research and development company specializing in oncology, announced the issuance of its annual Letter to Stockholders from President and CEO Steven A. Kriegsman. The Letter provides an overview of the Company’s business plan and is available on the Company’s website at www.cytrx.com. Excerpts from the Letter are as follows:

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES